3123-46-4 Usage
General Description
4-Oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, also known as 4-oxo-Tetrahydronaphthalene-1-carboxylic acid, is a chemical compound that belongs to the class of naphthalene carboxylic acids. It is a white to off-white powder with a molecular formula of C11H10O3. 4-Oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It has various applications in the pharmaceutical and chemical industries, including as a building block in the production of drugs and as a precursor for the synthesis of other organic compounds. Additionally, 4-Oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid is known for its potential as an anti-inflammatory and analgesic agent, making it a valuable compound in medicinal research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 3123-46-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,2 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3123-46:
(6*3)+(5*1)+(4*2)+(3*3)+(2*4)+(1*6)=54
54 % 10 = 4
So 3123-46-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H10O3/c12-10-6-5-9(11(13)14)7-3-1-2-4-8(7)10/h1-4,9H,5-6H2,(H,13,14)
3123-46-4Relevant articles and documents
(±)-4-Oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid: Hydrogen bonding and carboxyl disordering in a δ-keto acid
Thompson, Hugh W.,Lalancette, Roger A.,Brunskill, Andrew P. J.
, p. 1180 - 1182 (1998)
The crystal structure of the title compound (C11H10O3) contains hydrogen-bonded centrosymmetric carboxyl dimers. Significant carboxyl disorder was found, and was modeled by two rotational conformers, yielding two O...O distances of 2.649 (14) and 2.666 (17) A.
Aryl fused azapolycyclic compounds
-
Page/Page column 17, (2010/02/10)
This invention is directed to compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R1, R2, R3 and Z are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical com